10089 - Genetic Basis of Kidney Cancer: Critical Opportunity for a Genomic Future

Content Source

Adapted from a paper by W. Marston Linehan, MD, National Cancer Institute, National Institutes of Health

Description

Kidney cancer affects nearly 270,000 patients annually worldwide and is responsible for over 115,000 deaths each year. Kidney cancer is not a single disease; rather, it is comprised of a number of different genetically distinct types of cancer, each with a different histologic type, and each of which has a different clinical course and different responses to therapy. This course provides a detailed overview of the genetic basis of these cancers and the implications for effective therapy.

Credits

AMA PRA Category 1 Credits™

Opus Medicus designates this Internet enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC) Credits

In addition to AMA PRA Category 1 Credits™, Opus Medicus designates this course for Specialty Board MOC Program Credits:

3.0 ABP CC/MOC Credits1
3.0 ABIM MOC Points2

Accreditation Statement

Opus Medicus is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Tuition Fees

Course: Free
Credits: $78.00

Course Dates

Last Review Date: 16-Nov-2021
Expiration Date: 15-Nov-2024

Objectives

After taking this course, participants will have a clear understanding of the genetic abnormalities associated with each histologic type of kidney cancer and implications for specific treatments.

Topics

1. Clear Cell Kidney Cancer

2. Hereditary Papillary Renal Cell Carcinoma: Type 1 Papillary Kidney Cancer

3. Birt-Hogg-Dubé: The Hereditary Form of Chromophobe Kidney Cancer

4. Hereditary Leiomyomatosis Renal Cell Carcinoma: Type II Papillary Kidney Cancer

5. Succinate Dehydrogenase Kidney Cancer: SDH RCC

6. Tuberous Sclerosis Complex: TSC1/2

7. MiT Family Kidney Cancer: TFE3, TFEB and MITF

8. Kidney Cancer is a Metabolic Disease

9. Sporadic (Non-Familial) Kidney Cancer

10.What is the Genetic Basis of Non-Clear Cell Kidney Cancer?

American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Education (ACGME) Competencies

☑  Patient Care (PC)
☑  Medical Knowledge (MK)

Financial Relationship Disclosure and Content Attestation

All members of the course team attest that they have no financial relationships with commercial entities offering healthcare-related products or services relevant to the course content.

There has been no commercial support for this course.

Supported Computer Hardware and Software Configurations3

Supported client computing platforms include:

A broadband Internet connection is required (e.g., cable, DSL, and 3G or 4G wireless). The course presentation is automatically scaled to the size of the display, from 800x480 pixels (minimum supported) to 1920x1200 pixels. On some smart phones, viewing courses may be tedious.

Supported browsers include:

Javascript, cookies, and popups must be enabled on your browser (which is the default configuration for most browsers).

1. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 CC/MOC credits for the American Board of Pathology (ABP) Continuing Certification (CC) / Maintenance of Certification (MOC) Program, in addition to AMA PRA Category 1 Credits™. Participants will earn CC/MOC credits equivalent to the amount of AMA PRA Category 1 credits claimed for the activity. Immediately upon course completion, Opus Medicus will submit participant completion information to ACCME for the purpose of granting ABP CC/MOC credit.

2. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points for the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Program, in addition to AMA PRA Category 1 Credits™. Participants will earn MOC points equivalent to the amount of AMA PRA Category 1 credits claimed for the activity. Immediately upon course completion, Opus Medicus will submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

3. The course may also be viewable on other client computing platforms that comply with Internet standards. If you experience technical problems that prevent you from viewing the course, we will promptly issue a full refund upon request.